Should She Discontinue Aspirin
This 83-year-old woman should discontinue her daily aspirin 81 mg, as current evidence shows no net benefit and potential harm from aspirin for primary prevention in her age group, particularly given the absence of established cardiovascular disease.
Rationale Based on Current Guidelines
The most recent and authoritative guidance comes from the 2019 ACC/AHA Primary Prevention Guidelines 1, which fundamentally changed recommendations for aspirin use. For adults over 70 years of age, prophylactic aspirin is considered potentially harmful due to increased bleeding risk that outweighs any cardiovascular benefit 1. This represents a significant shift from older guidelines.
Key Evidence Against Continuation:
Age-Specific Concerns:
- At 83 years old, she falls well above the 70-year threshold where bleeding risks substantially exceed benefits 1
- The 2019 guidelines specifically state that routine aspirin use in adults >70 years is difficult to justify given higher bleeding risk 1
- Recent trials (ASPREE, 2018) in adults >65 years found no reduction in cardiovascular events but increased risk of bleeding and death 2
Primary Prevention Context:
- She has no history of stroke or MI, meaning this is primary prevention, not secondary prevention
- The 2011 AHA Stroke Prevention Guidelines explicitly state: "Aspirin is not useful for preventing a first stroke in persons at low risk" (Class III recommendation) 3
- Multiple recent trials (ASCEND, ARRIVE, ASPREE from 2018) showed lack of net benefit for primary prevention, with bleeding risks counterbalancing any cardiovascular benefit 2
The "Thick Blood" Justification is Not Valid:
The previous provider's rationale of "thick blood" is not a recognized medical indication for aspirin therapy. Aspirin works by inhibiting platelet aggregation, not by "thinning blood" in the way anticoagulants do. Without documented cardiovascular disease, elevated cardiovascular risk scores, or specific conditions requiring antiplatelet therapy, this reasoning lacks clinical foundation.
Bleeding Risk Considerations:
At 83 years old, she faces significantly elevated risks:
- Gastrointestinal bleeding requiring transfusion increases with age 4
- Risk is particularly high if she's on other NSAIDs, has history of ulcers, or consumes alcohol 4
- Hemorrhagic stroke risk increases, which can be catastrophic 3, 5
- The number needed to harm (210) is actually lower than the number needed to treat to prevent an ASCVD event (265) in recent meta-analyses 2
When Aspirin WOULD Be Appropriate:
For context, aspirin would be indicated if she had:
- Established cardiovascular disease (prior MI, stroke, peripheral arterial disease) - this would be secondary prevention 6, 7
- Very high 10-year ASCVD risk (≥20%) with other uncontrolled risk factors, though even this is controversial in her age group 1
- Specific conditions like atrial fibrillation (though anticoagulation would be preferred) 8
Clinical Action Steps:
- Discontinue the aspirin - there is no evidence-based indication for its continuation
- Assess her actual cardiovascular risk factors: hypertension, diabetes, hyperlipidemia, smoking status
- Optimize evidence-based primary prevention:
- Blood pressure control (target <130/80 if tolerated)
- Statin therapy if indicated by lipid levels and risk assessment
- Diabetes management if present
- Lifestyle modifications (diet, exercise, smoking cessation)
- Document the rationale for discontinuation in her medical record
Important Caveat:
If upon further evaluation she actually has undiagnosed cardiovascular disease (prior silent MI, significant carotid stenosis, peripheral arterial disease, etc.), then aspirin would be appropriate as secondary prevention 6, 7. However, based on the information provided stating "no history of stroke or MI," discontinuation is the appropriate recommendation.
The evidence strongly supports that the risks of continuing aspirin in this 83-year-old woman without established cardiovascular disease outweigh any potential benefits 2, 1.